Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Composés actifs
Mécanisme d'action
Preuves cliniques
Supplementation with 1g or 3g of AHCC for 12 weeks significantly changed alanine aminotransferase (ALT) levels compared to placebo [PMID:25744424]
Patients receiving 6.0g of AHCC for 2 months showed significantly suppressed C-reactive protein (CRP) elevation, reduced albumin decline, and a lower frequency of taste disorders compared to controls [PMID:26847832]
AHCC was investigated for its ability to prolong survival and improve prognosis in patients with advanced hepatocellular carcinoma [PMID:16913187]
Daily intake of 3.0g for 4 weeks significantly increased the number of total circulating dendritic cells [PMID:18791928]
AHCC administration significantly decreased levels of HHV-6 in saliva and improved quality of life (QOL) scores during chemotherapy [PMID:24611562]
Sécurité et effets indésirables
Posologie et administration
Synthèse des preuves
Sources PubMed
- 1.PMID: 25744424 (2014) — Effect of Active Hexose Correlated Compound (AHCC) in alcohol-induced liver enzyme elevation. · Journal of nutritional science and vitaminology
- 2.PMID: 18791928 (2008) — Immunological effect of active hexose correlated compound (AHCC) in healthy volunteers: a double-blind, placebo-controlled trial. · Nutrition and cancer
- 3.PMID: 29111786 (2018) — Active Hexose Correlated Compound (AHCC) Inhibits the Proliferation of Ovarian Cancer Cells by Suppressing Signal Transducer and Activator of Transcription 3 (STAT3) Activation. · Nutrition and cancer
- 4.PMID: 16913187 (2006) — Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment. · Asian Pacific journal of allergy and immunology
- 5.PMID: 26847832